You are here: Industry Insights > cancer

News List

Erasca picks up $42M to target biological drivers of cancer fiercebiotech
December 25, 2018
Erasca has raised a $42 million series A round from the likes of City Hill Ventures and Cormorant Asset Management to work toward the lofty goal to “not just treat, but actually cure cancer.” ....
G1 tanks after placebo beats drug in cancer response rate test fiercebiotech
December 25, 2018
G1 Therapeutics’ cancer drug trilaciclib has failed to beat placebo against multiple efficacy measures in phase 2. Trilaciclib performed well against its neutropenia-related primary endpoints but....
Relay Therapeutics bags $400M to ramp up discovery and push into the clinic fiercebiotech
December 25, 2018
Two weeks after expanding its R&D team, Relay Therapeutics is reeling in a massive $400 million series C round to boost its platform technology and discovery efforts, build its pipeline and get into the clinic......
Merck KGaA, Intrexon Amend CAR-T Alliance contractpharma
December 21, 2018
Merck KGaA, Darmstadt, Germany, through its wholly owned subsidiary, Ares Trading, amended its agreement with Intrexon Corp.
Chi-Med and Lilly Amend 2013 Agreement contractpharma
December 21, 2018
Hutchison China MediTech has announced a change (“2018 Amendment”) to the 2013 License and Collaboration Agreement on fruquintinib with Lilly Shanghai, an affiliate of Eli Lilly and Company.
Exercise Linked to Reduced Mortality for Patients With Cancer drugs
December 19, 2018
For patients with cancer, participation in prediagnosis and postdiagnosis recreational physical activity is associated with reduced mortality....
Decryption of the Feminization Drug on the Internet Shanghai Xiaoyaoshi
December 19, 2018
The real scientific name (generic name) for stilbestrol or stilboestrol is diethylstilbestrol (DES), but not the “biethylstilbestrol” often mentioned online.
J&J hits back over asbestos in talc claims pharmaphorum
December 18, 2018
Shares in Johnson & Johnson slid around 10% on Friday after a Reuters article claimed the company had known for decades about asbestos in talcum powder products.
Pfizer’s cut-price version of Avastin wins EU panel greenlight expressbpd
December 18, 2018
Pfizer’s Zirabev is a cheaper version to Roche Holding’s leading cancer drug Avastin
KIO, Pfizer Enter Research Collaboration contractpharma
December 18, 2018
Kineta Immuno-Oncology has entered into a strategic research collaboration with Pfizer Inc. to develop RIG-I agonist immunotherapies for the treatment of cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page